← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Maryland Baltimore
Baltimore, MD
$4,720,094,728
Total funding
3,828
Grants
Funding over time
peak $296.4M · FY2005–25$500M$375M$250M$125M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,318,044,017 · 3724
CDC$339,872,789 · 39
FDA$39,689,031 · 16
AHRQ$22,463,891 · 43
ACF$25,000 · 1
SAMHSA$0 · 5
By mechanism
R01$2,235,796,622 · 1262
U01$333,246,468 · 99
U2G$322,736,380 · 12
N01$278,263,565 · 25
U19$198,229,551 · 122
R21$169,144,895 · 437
Investigators at University Of Maryland Baltimore
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
HIV/AIDS Prevention, Care and Treatment in the Federal Republic of Nigeria$63,754,551
U2G · FY2009 · PS
HIV/AIDS Prevention, Care and Treatment in the Federal Republic of Nigeria$55,961,295
U2G · FY2008 · PS
HIV/AIDS Prevention, Care and Treatment in the Federal Republic of Nigeria$43,943,602
U2G · FY2007 · PS
PROVIDING QUALITY COMPREHENSIVE HAIV/AIDS PREVENTION, CARE, AND TREATMENT SERVICE$24,000,000
U2G · FY2011 · PS
Radiation Nuclear Countermeasures Product Development Support Services Contract$17,960,336
N01 · FY2011 · AI
HIV/AIDS Prevention, Care and Treatment in the Federal Republic of Nigeria$15,938,637
U2G · FY2010 · PS
Radiation Nuclear Countermeasures Product Development Support Services Contract$14,001,751
N01 · FY2010 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site:21-0011$11,669,935
UM1 · FY2021 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE$11,506,068
N01 · FY2020 · AI
Medical Countermeasures Against Radiological Threats: Product Development Support$10,997,816
N01 · FY2013 · AI
Medical Countermeasures Against Radiological Threats: Product Development Support$10,385,899
N01 · FY2014 · AI
STOP MOTHER AND CHILD HIV TRANSMISSION$9,555,371
U2G · FY2016 · GH
Medical Countermeasures Against Radiological Threats: Product Development Support$9,427,820
N01 · FY2012 · AI
Defense against Biowarfare and Emerging Infection Agents$9,378,104
U54 · FY2006 · AI
Defense against Biowarfare and Emerging Infection Agents$9,124,674
U54 · FY2004 · AI
Middle Atlantic Regional Center for Excellence for Biodefense and Emerging Infect$9,047,135
U54 · FY2010 · AI
Defense against Biowarfare and Emerging Infection Agents$9,038,291
U54 · FY2008 · AI
Medical Countermeasures Against Radiological Threats: Product Development Support$8,996,042
N01 · FY2008 · AI
Defense against Biowarfare and Emerging Infection Agents$8,974,451
U54 · FY2007 · AI
Defense against Biowarfare and Emerging Infection Agents$8,963,750
U54 · FY2005 · AI